Visualizing Vascular Mechanisms of Salt Sensitivity
Sponsor:
Vanderbilt University Medical Center
Collaborators:
Information provided by (Responsible Party):
Rachelle Crescenzi,Vanderbilt University Medical Center
Tracking Information | |||
---|---|---|---|
First Submitted Date ICMJE | September 25, 2018 | ||
First Posted Date ICMJE | October 4, 2018 | ||
Last Update Posted Date | October 4, 2018 | ||
Actual Study Start Date ICMJE | November 1, 2018 | ||
Estimated Primary Completion Date | February 28, 2021 (Final data collection date for primary outcome measure) | ||
Current Primary Outcome Measures ICMJE |
Change in Salt-sensitive blood pressure after low salt diet[ Time Frame: Following completion of all dietary supplements and washout, in no less than 21 days. ] Measured as the difference in mean arterial pressure following high-salt diet compared to low-salt diet |
||
Original Primary Outcome Measures ICMJE | Same as current | ||
Current Secondary Outcome Measures ICMJE |
|
||
Descriptive Information | |||
Brief Title ICMJE | Visualizing Vascular Mechanisms of Salt Sensitivity |
||
Official Title ICMJE | Visualizing Vascular Mechanisms of Salt Sensitivity |
||
Brief Summary | This study aims to assess the salt sensitive blood pressure response to dietary salt load compared with radiological markers of salt handling. |
||
Detailed Description | Hypertension is a major cause of heart disease, heart failure, and stroke. Hypertension, or high blood pressure, affects people differently and is related to the body's ability to maintain healthy circulation of salt. Some individuals may be affected by salt sensitive blood pressure (SSBP), when their blood pressure changes in response to dietary salt load. SSBP is a prevalent, independent risk factor for developing cardiovascular disease that preferentially affects black individuals. Current methods to assess SSBP require dietary salt loading over the course of days to weeks, and measurement of blood pressure following high salt diet and low salt diet. Such lengthy protocols are not feasible in a clinical setting to evaluate this risk factor for cardiovascular disease, and more importantly, these procedures provide incomplete information about mechanisms of salt sensitivity. Our knowledge regarding salt handling in the body is limited. While renal dysfunction is partly responsible for SSBP, recent research points to the role of lymphatic vascular clearance in regulating tissue salt storage and blood pressure control. To better understand these mechanisms in vivo, we have recently developed a noninvasive magnetic resonance (MR) lymphangiography method sensitive to lymphatic vasculature, and applied standardized MR protocols for measuring tissue sodium and fat storage in adults with impaired lymphatic clearance. We found evidence of lymph stasis and tissue salt deposition that correlated with local subcutaneous fat volume. Here, we will test whether similar lymphatic pathways are impaired in persons with SSBP, leading to tissue salt and fat storage, in comparison to the involvement of renal dysfunction in SSBP tissue profiles. The aims of this study are to improve our understanding of vascular mechanisms of human salt storage, and to provide standardized radiologic biomarkers sensitive to the SSBP phenotype. This study will test the primary hypothesis that the SSBP response is correlated with baseline tissue sodium storage, and elevated in persons with salt sensitivity. Secondary hypotheses will address whether the SSBP response is related to fat storage, lymphatic vascular function, renal vascular function, and impaired target organ responses to salt loading, including decreased urinary sodium excretion, and less suppression of plasma renin and serum aldosterone. | ||
Study Type ICMJE | Interventional | ||
Study Phase | N/A | ||
Study Design ICMJE | Allocation: Randomized Intervention Model: Crossover Assignment Intervention Model Description: Masking: Interventional Masking Description: Primary Purpose: Basic Science |
||
Condition ICMJE | |||
Intervention ICMJE |
|
||
Study Arms |
|
||
Recruitment Information | |||
Recruitment Status ICMJE | Not yet recruiting | ||
Estimated Enrollment ICMJE |
20 | ||
Original Estimated Enrollment ICMJE | Same as current | ||
Estimated Study Completion Date | June 30, 2021 | ||
Estimated Primary Completion Date | February 28, 2021 (Final data collection date for primary outcome measure) | ||
Eligibility Criteria ICMJE | Inclusion Criteria: - Identification as black race - Age between 18 and 55 years - Body mass index between 25 and <35 kg/m2 - Normotensive or pre-hypertensive - Willing to adhere to study diets - Able to provide informed consent and communicate with study personnel Exclusion Criteria: - Prevalent cardiovascular disease or use of medications for cardiovascular disease - Current or prior history of hypertension or use of blood pressure lowering medications - Current or prior history of diabetes mellitus or use of anti-diabetic medications - Prevalent renal disease (eGFR < 60 ml/min/1.73m2), abnormal serum sodium or potassium - Current or prior smoker - Current pregnancy, or use of hormone replacement therapy or oral contraceptive - Current steroid use - Contraindications to MRI - Active infection or open wounds on the top of the feet or hands | ||
Sex/Gender |
|
||
Ages | 18 Years and older (Adult, Older Adult) | ||
Accepts Healthy Volunteers | No | ||
Listed Location Countries ICMJE | United States | ||
Removed Location Countries | |||
Administrative Information | Has Data Monitoring Committee | No | |
U.S. FDA-regulated Product |
Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No |
||
IPD Sharing Statement |
|
||
Responsible Party | Rachelle Crescenzi,Vanderbilt University Medical Center | ||
Study Sponsor ICMJE | Vanderbilt University Medical Center | ||
Collaborators ICMJE | |||
Investigators ICMJE |
|
||
PRS Account | Vanderbilt University Medical Center | ||
Verification Date | October 2018 | ||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
请使用微信扫码报名